EG20562A - Process for preparing glutaramide derivatives - Google Patents

Process for preparing glutaramide derivatives

Info

Publication number
EG20562A
EG20562A EG75294A EG75294A EG20562A EG 20562 A EG20562 A EG 20562A EG 75294 A EG75294 A EG 75294A EG 75294 A EG75294 A EG 75294A EG 20562 A EG20562 A EG 20562A
Authority
EG
Egypt
Prior art keywords
preparing
glutaramide derivatives
glutaramide
derivatives
alpha
Prior art date
Application number
EG75294A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of EG20562A publication Critical patent/EG20562A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/06Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
EG75294A 1993-12-04 1994-12-01 Process for preparing glutaramide derivatives EG20562A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939324931A GB9324931D0 (en) 1993-12-04 1993-12-04 Glutaramide derivatives

Publications (1)

Publication Number Publication Date
EG20562A true EG20562A (en) 1999-08-30

Family

ID=10746163

Family Applications (1)

Application Number Title Priority Date Filing Date
EG75294A EG20562A (en) 1993-12-04 1994-12-01 Process for preparing glutaramide derivatives

Country Status (26)

Country Link
US (1) US6180665B1 (pl)
EP (1) EP0731787B1 (pl)
JP (1) JP2701988B2 (pl)
KR (1) KR100203314B1 (pl)
CN (1) CN1068586C (pl)
AT (1) ATE175664T1 (pl)
CA (1) CA2178085C (pl)
CZ (1) CZ296428B6 (pl)
DE (1) DE69416003T2 (pl)
DK (1) DK0731787T3 (pl)
EG (1) EG20562A (pl)
ES (1) ES2128031T3 (pl)
FI (1) FI120305B (pl)
GB (1) GB9324931D0 (pl)
GR (1) GR3029590T3 (pl)
HU (1) HU225959B1 (pl)
IL (1) IL111791A (pl)
MY (1) MY115430A (pl)
NO (1) NO306714B1 (pl)
NZ (1) NZ276087A (pl)
PE (1) PE9296A1 (pl)
PL (1) PL178559B1 (pl)
RU (1) RU2131869C1 (pl)
TW (2) TW434210B (pl)
WO (1) WO1995015308A1 (pl)
ZA (1) ZA949595B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001287405A1 (en) 2000-08-29 2002-03-13 Riverside Forest Products Limited Collapsible bin
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
US6975515B2 (en) 2001-08-15 2005-12-13 Agilent Technologies, Inc. Electrical module
CN102285916B (zh) * 2003-02-12 2015-02-25 日产化学工业株式会社 匹伐他汀钙的晶形
WO2005123702A1 (en) * 2004-06-15 2005-12-29 Pfizer Limited Neutral endopeptidase inhibitor polymorph
CN109350736A (zh) * 2018-09-20 2019-02-19 南通大学 防治运动病、梅尼埃病的药物及心房钠尿肽的医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
US5208236A (en) 1992-09-23 1993-05-04 Schering Corporation N-(acylaminomethyl)glutaryl amino acids and use

Also Published As

Publication number Publication date
CZ296428B6 (cs) 2006-03-15
TW434210B (en) 2001-05-16
CA2178085A1 (en) 1995-06-08
HU225959B1 (en) 2008-01-28
GR3029590T3 (en) 1999-06-30
FI962322A0 (fi) 1996-06-03
ZA949595B (en) 1996-06-03
IL111791A0 (en) 1995-01-24
PE9296A1 (es) 1996-04-04
PL314794A1 (en) 1996-09-30
NO962294L (no) 1996-06-04
DE69416003T2 (de) 1999-05-27
DK0731787T3 (da) 1999-08-30
CN1142816A (zh) 1997-02-12
FI120305B (fi) 2009-09-15
JPH09500654A (ja) 1997-01-21
ATE175664T1 (de) 1999-01-15
AU8142494A (en) 1995-06-19
DE69416003D1 (en) 1999-02-25
US6180665B1 (en) 2001-01-30
WO1995015308A1 (en) 1995-06-08
RU2131869C1 (ru) 1999-06-20
CZ160496A3 (en) 1996-11-13
ES2128031T3 (es) 1999-05-01
PL178559B1 (pl) 2000-05-31
IL111791A (en) 2002-09-12
EP0731787B1 (en) 1999-01-13
HU9601506D0 (en) 1996-07-29
AU684114B2 (en) 1997-12-04
CA2178085C (en) 2002-09-03
JP2701988B2 (ja) 1998-01-21
KR960706470A (ko) 1996-12-09
KR100203314B1 (ko) 1999-06-15
NO306714B1 (no) 1999-12-13
CN1068586C (zh) 2001-07-18
FI962322L (fi) 1996-06-03
NZ276087A (en) 1997-11-24
NO962294D0 (no) 1996-06-04
MY115430A (en) 2003-06-30
HUT74683A (en) 1997-01-28
GB9324931D0 (en) 1994-01-26
EP0731787A1 (en) 1996-09-18
TW534901B (en) 2003-06-01

Similar Documents

Publication Publication Date Title
MY111556A (en) Substituted azadioxacycloalkenes.
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
CA2033392A1 (en) A-nor-steroid-3-carboxylic acid derivatives
AU7116691A (en) Process for the preparation of oxetanones
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
IL112622A (en) Iminoalkylamino or aminoalkylideneamino camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
AU1280392A (en) Urea derivatives
IL118366A0 (en) Vitamin D derivatives a process for the preparation thereof and pharmaceutical compositions containing the same
MY107819A (en) Preparation of substituted piperidines.
BG103778A (en) Process for preparing pyrazole derivatives
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
AP9300561A0 (en) Antibiotic compounds.
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
TW252979B (pl)
CA2256559A1 (en) N-bis- or n-tris-[(1,2-dicarboxy-ethoxy)-ethyl]-amine derivatives and preparation and use of the same
IL107068A0 (en) 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes,their preparation and pharmaceutical compositions containing them
EG20562A (en) Process for preparing glutaramide derivatives
CA2007261A1 (en) Novel tetralin derivatives
ZA200005110B (en) Process for preparing intermediates.
GB9920959D0 (en) Novel process
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
AU7206898A (en) Method for producing 1,3-di-substituted 2-nitroguanidines